What exactly does a telehealth provider evaluate before prescribing a GLP-1? If you're picturing a quick glance at a questionnaire and a rubber-stamped prescription, that's a red flag — not the standard. Legitimate virtual weight loss visits involve the same clinical decision-making as an in-office encounter, just delivered through a screen.
The Pre-Visit Health Intake
Before you ever speak to (or message) a provider, you'll complete a detailed health intake. This isn't the same as a customer signup form. A thorough intake collects your current weight, height, and waist circumference for BMI calculation, a complete medical history including cardiovascular events, thyroid conditions, pancreatitis, gallbladder disease, and kidney impairment, a medication list covering prescriptions, OTC drugs, and supplements, allergy history including reactions to any injectables, family history specifically asking about medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2), previous weight loss methods and their outcomes, and mental health screening for eating disorders.
Why MTC/MEN 2 Screening Matters
All GLP-1 receptor agonists carry a boxed warning about thyroid C-cell tumors observed in animal studies. A personal or family history of medullary thyroid carcinoma or MEN 2 syndrome is an absolute contraindication. Any platform that skips this question is cutting a dangerous corner.
The Clinical Evaluation
Your provider reviews the intake and looks for three things: eligibility (do you meet the BMI threshold?), safety (are there contraindications?), and appropriateness (is a GLP-1 the right treatment, or would something else serve you better?).
Contraindications that should halt or delay prescribing include a personal or family history of MTC or MEN 2, current or recent pancreatitis, severe gastroparesis, pregnancy or planned pregnancy, a history of serious hypersensitivity to semaglutide or tirzepatide, and end-stage renal disease. Relative contraindications — conditions where prescribing requires extra caution — include a history of gallbladder disease, retinopathy (for patients with diabetes), severe hepatic impairment, and active suicidal ideation.
Lab Requirements: The 2026 Landscape
There's no universal requirement that labs must be completed before starting a GLP-1. However, clinical best practice — endorsed by the Obesity Medicine Association — recommends baseline labs including a comprehensive metabolic panel (CMP), HbA1c for diabetes screening, lipid panel, and thyroid function tests (TSH at minimum).
Some platforms require labs before prescribing. Others recommend them but allow treatment to begin while labs are pending. A third category doesn't mention labs at all — which isn't ideal but isn't necessarily disqualifying if the provider conducts a thorough clinical evaluation by other means.
Medication Selection
If you're approved, your provider selects the appropriate medication and starting dose. This isn't always semaglutide. Depending on your profile, they might recommend tirzepatide (a dual GIP/GLP-1 agonist with stronger weight loss data), a lower starting dose if you have a history of GI sensitivity, or brand-name over compounded based on your preferences and budget. Every GLP-1 starts with a titration protocol — low dose increasing over time — to minimize side effects. Providers who prescribe high doses from day one are cutting corners.
Wellorithm
Starting from $350 CPAStructured evaluations with titration-based care plans.
⚠️ Compounded medications are not FDA-approved.
The Prescribing Decision
Not everyone gets prescribed. Legitimate platforms report denial rates between 5% and 15%, depending on how rigorously they screen. Common reasons for denial include BMI below the threshold without qualifying comorbidities, active contraindications identified during the evaluation, unrealistic expectations (seeking GLP-1s for cosmetic weight loss of 5–10 lbs), or incomplete health information that prevents safe prescribing.
If your application is denied, a quality platform will explain why and suggest alternatives — whether that's a different treatment approach, a referral to an in-person specialist, or a recommendation to complete additional testing before reapplying.
Key Takeaway
A thorough virtual GLP-1 evaluation covers the same clinical ground as an in-person visit: BMI verification, contraindication screening, medication selection, and a titration plan. The delivery method is different; the medical standard should be identical.
Questions to Ask Your Virtual Provider
Before your visit, prepare these questions: What is your titration schedule? What side effects should I watch for, and when should I contact you? Do you recommend baseline labs? Will I see the same provider for follow-ups? What happens if I need to switch medications? What's your process if I experience severe side effects between visits?
A provider who answers these questions clearly — without rushing — is one worth trusting.
Oak Longevity
Provider consultations with personalized treatment plans.
⚠️ Compounded medications are not FDA-approved.